These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1865334)

  • 1. 5-Acyl-6-aryl-4-nitro-3(2H)pyridazinones and related 4-amino compounds: synthesis and pharmacological evaluation.
    Dal Piaz V; Ciciani G; Turco G; Giovannoni MP; Miceli M; Pirisino R; Perretti M
    J Pharm Sci; 1991 Apr; 80(4):341-8. PubMed ID: 1865334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted congeners of hypotensive and platelet aggregation inhibitors: 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones derived from 5H-indeno[1,2-c]pyridazine.
    Cignarella G; Barlocco D; Pinna GA; Loriga M; Tofanetti O; Germini M; Sala F
    J Med Chem; 1986 Nov; 29(11):2191-4. PubMed ID: 3783580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
    Laguna R; Rodriguez-Liñares B; Cano E; Estevez I; Raviña E; Sotelo E
    Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1151-5. PubMed ID: 9246748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophages.
    Dal Piaz V; Giovannoni MP; Ciciani G; Becherucci C; Parente L
    Pharmacol Res; 1994; 29(4):367-72. PubMed ID: 7971688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of N-substituted 4,6-diaryl-3-pyridazinones as analgesic, antiinflammatory and antipyretic agents.
    Rubat C; Coudert P; Tronche P; Bastide J; Bastide P; Privat AM
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2832-5. PubMed ID: 2611945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions.
    Sotelo E; Fraiz N; Yáñez M; Terrades V; Laguna R; Cano E; Raviña E
    Bioorg Med Chem; 2002 Sep; 10(9):2873-82. PubMed ID: 12110307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
    Jiang Q; Sun CS
    Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone and related compounds.
    Takaya M; Sato M; Terashima K; Tanizawa H; Maki Y
    J Med Chem; 1979 Jan; 22(1):53-8. PubMed ID: 311385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.
    Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1574-7. PubMed ID: 12499593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
    Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
    Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones.
    Coelho A; Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
    Bioorg Med Chem Lett; 2004 Jan; 14(2):321-4. PubMed ID: 14698150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones.
    Cignarella G; Barlocco D; Pinna GA; Loriga M; Curzu MM; Tofanetti O; Germini M; Cazzulani P; Cavalletti E
    J Med Chem; 1989 Oct; 32(10):2277-82. PubMed ID: 2795599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.
    Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Brea J; Raviña E
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1575-7. PubMed ID: 12039565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities.
    Thyes M; Lehmann HD; Gries J; König H; Kretzschmar R; Kunze J; Lebkücher R; Lenke D
    J Med Chem; 1983 Jun; 26(6):800-7. PubMed ID: 6854582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on pyridazinone derivatives. XVI. Analgesic-antiinflammatory activities of 3(2H)-pyridazinone derivatives].
    Takaya M; Sato M
    Yakugaku Zasshi; 1994 Feb; 114(2):94-110. PubMed ID: 8169774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
    Huang WH; Lee AR; Chien PY; Chou TC
    J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones.
    Pinna GA; Curzu MM; Barlocco D; Cignarella G; Cavalletti E; Germini M; Berger K
    Farmaco Sci; 1988 Jun; 43(6):539-49. PubMed ID: 3208896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
    Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
    J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.